☆ 4.3 Editorial Material

The inherent ethical challenge of first-in-human pluripotent stem cell trials

REGENERATIVE MEDICINE (2014)

Get Full Text
Add to Collection

Journal

REGENERATIVE MEDICINE
Volume 9, Issue 1, Pages 1-3

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/RME.13.83

Keywords

ethics; first-in-human trials; induced pluripotent stem cells; iPS cells; pluripotent stem cells; research ethics; risk-benefit; social value; translational medicine

Categories

Cell & Tissue Engineering Engineering, Biomedical

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.